Skip to content
healthcare.dev

Ryzumvi

NDC 83368-075, phentolamine mesylate, solution/ drops, from Oyster Point Pharma, Inc..

Product NDC
83368-075
Status
Listed
Labeler
Oyster Point Pharma, Inc.
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217064
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83368-075 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENTOLAMINE MESYLATE10 mg/mL

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
83368-075-30833680075306 POUCH in 1 CARTON (83368-075-30) / 5 VIAL, SINGLE-USE in 1 POUCH / .2 mL in 1 VIAL, SINGLE-USE
83368-075-31833680075311 POUCH in 1 CARTON (83368-075-31) / 5 VIAL, SINGLE-USE in 1 POUCH / .2 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/96bb1e53-c2cc-4e60-a21a-db0269c371bf

Use it

Look up 83368-075 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83368-075 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83368-075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.